Annual Long Term Debt
$923.85 M
-$13.90 M-1.48%
31 December 2023
Summary:
Pacific Biosciences of California annual long term debt is currently $923.85 million, with the most recent change of -$13.90 million (-1.48%) on 31 December 2023. During the last 3 years, it has risen by +$886.18 million (+2352.67%). PACB annual long term debt is now -2.35% below its all-time high of $946.04 million, reached on 31 December 2021.PACB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$910.08 M
-$2.39 M-0.26%
30 September 2024
Summary:
Pacific Biosciences of California quarterly long term debt is currently $910.08 million, with the most recent change of -$2.39 million (-0.26%) on 30 September 2024. Over the past year, it has dropped by -$16.02 million (-1.73%). PACB quarterly long term debt is now -3.80% below its all-time high of $946.04 million, reached on 31 December 2021.PACB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.5% | -1.7% |
| 3 y3 years | +2352.7% | -3.8% |
| 5 y5 years | +6202.3% | +2018.0% |
PACB Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.4% | +2352.7% | -3.8% | at low |
| 5 y | 5 years | -2.4% | +6202.3% | -3.8% | +2316.1% |
| alltime | all time | -2.4% | -3.8% |
Pacific Biosciences Of California Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $910.08 M(-0.3%) |
| June 2024 | - | $912.46 M(-1.0%) |
| Mar 2024 | - | $921.59 M(-0.2%) |
| Dec 2023 | $923.85 M(-1.5%) | $923.85 M(-0.2%) |
| Sept 2023 | - | $926.10 M(-0.2%) |
| June 2023 | - | $928.39 M(-0.8%) |
| Mar 2023 | - | $935.81 M(-0.2%) |
| Dec 2022 | $937.75 M(-0.9%) | $937.75 M(-0.2%) |
| Sept 2022 | - | $939.69 M(-0.2%) |
| June 2022 | - | $941.87 M(-0.2%) |
| Mar 2022 | - | $943.96 M(-0.2%) |
| Dec 2021 | $946.04 M(+2411.6%) | $946.04 M(+0.0%) |
| Sept 2021 | - | $945.87 M(+1.6%) |
| June 2021 | - | $931.19 M(-0.1%) |
| Mar 2021 | - | $932.16 M(+2374.7%) |
| Dec 2020 | $37.67 M(-10.2%) | $37.67 M(-2.9%) |
| Sept 2020 | - | $38.79 M(-2.7%) |
| June 2020 | - | $39.86 M(-2.5%) |
| Mar 2020 | - | $40.90 M(-2.5%) |
| Dec 2019 | $41.96 M(+186.3%) | $41.96 M(-2.3%) |
| Sept 2019 | - | $42.97 M(-2.2%) |
| June 2019 | - | $43.92 M(-2.1%) |
| Mar 2019 | - | $44.86 M(+206.0%) |
| Dec 2018 | $14.66 M(+7.5%) | $14.66 M(+1.9%) |
| Sept 2018 | - | $14.38 M(+1.9%) |
| June 2018 | - | $14.12 M(+1.8%) |
| Mar 2018 | - | $13.87 M(+1.7%) |
| Dec 2017 | $13.63 M | $13.63 M(+30.4%) |
| Sept 2017 | - | $10.46 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $10.44 M(-21.5%) |
| Mar 2017 | - | $13.30 M(-17.4%) |
| Dec 2016 | $16.11 M(+7.7%) | $16.11 M(+2.0%) |
| Sept 2016 | - | $15.79 M(+1.9%) |
| June 2016 | - | $15.50 M(+1.8%) |
| Mar 2016 | - | $15.22 M(+1.8%) |
| Dec 2015 | $14.95 M(+6.8%) | $14.95 M(+0.9%) |
| Sept 2015 | - | $14.81 M(+1.7%) |
| June 2015 | - | $14.57 M(+1.6%) |
| Mar 2015 | - | $14.34 M(+2.5%) |
| Dec 2014 | $13.99 M(+4.8%) | $13.99 M(+0.6%) |
| Sept 2014 | - | $13.91 M(+1.5%) |
| June 2014 | - | $13.71 M(-13.6%) |
| Mar 2014 | - | $15.87 M(+18.9%) |
| Dec 2013 | $13.35 M(+410.8%) | $13.35 M(-14.6%) |
| Sept 2013 | - | $15.63 M(+0.7%) |
| June 2013 | - | $15.52 M(+0.7%) |
| Mar 2013 | - | $15.42 M(+490.0%) |
| Dec 2012 | $2.61 M(-6.2%) | $2.61 M(-1.7%) |
| Sept 2012 | - | $2.66 M(-1.7%) |
| June 2012 | - | $2.71 M(-1.5%) |
| Mar 2012 | - | $2.75 M(-1.4%) |
| Dec 2011 | $2.79 M(-4.8%) | $2.79 M(-1.3%) |
| Sept 2011 | - | $2.82 M(-1.3%) |
| June 2011 | - | $2.86 M(-1.2%) |
| Mar 2011 | - | $2.90 M(-1.1%) |
| Dec 2010 | $2.93 M(>+9900.0%) | $2.93 M(+0.3%) |
| Sept 2010 | - | $2.92 M(>+9900.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00 |
| Dec 2008 | $0.00 | - |
FAQ
- What is Pacific Biosciences of California annual long term debt?
- What is the all time high annual long term debt for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual long term debt year-on-year change?
- What is Pacific Biosciences of California quarterly long term debt?
- What is the all time high quarterly long term debt for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly long term debt year-on-year change?
What is Pacific Biosciences of California annual long term debt?
The current annual long term debt of PACB is $923.85 M
What is the all time high annual long term debt for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual long term debt is $946.04 M
What is Pacific Biosciences of California annual long term debt year-on-year change?
Over the past year, PACB annual long term debt has changed by -$13.90 M (-1.48%)
What is Pacific Biosciences of California quarterly long term debt?
The current quarterly long term debt of PACB is $910.08 M
What is the all time high quarterly long term debt for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly long term debt is $946.04 M
What is Pacific Biosciences of California quarterly long term debt year-on-year change?
Over the past year, PACB quarterly long term debt has changed by -$16.02 M (-1.73%)